Snowden Capital Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Snowden Capital Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $20,765 - $25,729	-279 Reduced 3.81%	7,047 $580,000
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $6,704 - $7,920	-80 Reduced 1.08%	7,326 $639,000
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $134,604 - $173,968	1,766 Added 31.31%	7,406 $714,000
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $935 - $1,039	-11 Reduced 0.19%	5,640 $499,000
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $3,467 - $4,012	-40 Reduced 0.7%	5,651 $489,000
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $21,496 - $28,731	245 Added 4.5%	5,691 $553,000
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $47,505 - $63,765	587 Added 12.08%	5,446 $563,000
Q3 2022 Nov 09, 2022	BUY	$82.16 - $96.94 $146,409 - $172,747	1,782 Added 57.91%	4,859 $411,000
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $219,943 - $267,237	3,077 New	3,077 $254,000
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $16,118 - $20,113	-217 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $15,563 - $19,848	217 New	217 $19,000
Q1 2020 Jan 08, 2024	SELL	$71.37 - $96.85 $2.91 Million - $3.95 Million	-40,800 Closed	0 $0
Q4 2019 Jan 08, 2024	SELL	$64.27 - $86.37 $237,798 - $319,569	-3,700 Reduced 8.31%	40,800 $34.5 Million
Q3 2019 Jan 08, 2024	BUY	$67.4 - $85.11 $2.62 Million - $3.31 Million	38,860 Added 689.01%	44,500 $30 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.